FR957M - - Google Patents

Info

Publication number
FR957M
FR957M FR849005A FR849005A FR957M FR 957 M FR957 M FR 957M FR 849005 A FR849005 A FR 849005A FR 849005 A FR849005 A FR 849005A FR 957 M FR957 M FR 957M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR849005A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR849005A priority Critical patent/FR957M/fr
Application granted granted Critical
Publication of FR957M publication Critical patent/FR957M/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR849005A 1959-10-12 1961-01-06 Active FR957M (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR849005A FR957M (de) 1959-10-12 1961-01-06

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US84559559A 1959-10-12 1959-10-12
US84559459A 1959-10-12 1959-10-12
US84566159A 1959-10-12 1959-10-12
FR840981A FR1428454A (fr) 1959-10-12 1960-10-12 Dioxy-stéroïdes et leurs procédés de préparation
FR849005A FR957M (de) 1959-10-12 1961-01-06

Publications (1)

Publication Number Publication Date
FR957M true FR957M (de) 1961-11-27

Family

ID=27420319

Family Applications (2)

Application Number Title Priority Date Filing Date
FR840981A Expired FR1428454A (fr) 1959-10-12 1960-10-12 Dioxy-stéroïdes et leurs procédés de préparation
FR849005A Active FR957M (de) 1959-10-12 1961-01-06

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR840981A Expired FR1428454A (fr) 1959-10-12 1960-10-12 Dioxy-stéroïdes et leurs procédés de préparation

Country Status (7)

Country Link
BE (1) BE595971A (de)
CH (1) CH392500A (de)
DE (1) DE1188079B (de)
DK (1) DK108281C (de)
FR (2) FR1428454A (de)
GB (2) GB959377A (de)
NL (1) NL6810178A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069322A (en) * 1976-10-12 1978-01-17 Interx Research Corporation Pro-drugs for the improved delivery of certain selected anti-inflammatory steroids
KR101591482B1 (ko) 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 NF-κB 의 비호르몬성 스테로이드 조절제
EP2556083A4 (de) 2010-04-05 2013-12-04 Validus Biopharma Inc Nichthormonale steroide modulatoren von nf-kappa-b zur krankheitsbehandlung
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2866799A (en) * 1957-01-02 1958-12-30 Merck & Co Inc Method for converting a 17-20, 20-21 bismethylenedioxy or a 17-20, 20-21 bis-substituted methylenedioxy steroid of the pregnane series to a 17alpha, 21-dihydroxy-20-ketosteroid of the pregnane series

Also Published As

Publication number Publication date
DK108281C (da) 1967-11-06
FR1428454A (fr) 1966-02-18
GB959377A (en) 1964-06-03
BE595971A (fr) 1961-02-01
NL6810178A (de) 1968-10-25
CH392500A (de) 1965-05-31
DE1188079B (de) 1965-03-04
GB959378A (en) 1964-06-03

Similar Documents

Publication Publication Date Title
FR957M (de)
FR550M (de)
FR1193864A (de)
NL258016A (de)
BE584608A (de)
BE549973A (de)
NL6915824A (de)
NL6605056A (de)
NL6502540A (de)
NL258633A (de)
NL256842A (de)
NL255464A (de)
NL253806A (de)
NL251981A (de)
LU39553A1 (de)
LU37370A1 (de)
BE678810A (de)
BE620887A (de)
BE593371A (de)
BE589180A (de)
BE586349A (de)
BE586328A (de)
BE586314A (de)
BE586312A (de)
BE586050A (de)